Chlorhexidine Gluconate
CAS 18472-51-0
Chlorhexidine Gluconate (CAS 18472-51-0) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 1,999 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| CHLORHEXIDINE DIGLUCONATE | 20791 | SU | MTHSPL |
| chlorhexidine gluconate | 20791 | SU | MTHSPL |
| Chlorhexidine Gluconate | 20791 | SU | MTHSPL |
| CHLORHEXIDINE GLUCONATE | 20791 | SU | MTHSPL |
| chlorhexidine gluconate | 20791 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Chlorhexidine Gluconate used for in pharmaceutical contexts?
Chlorhexidine Gluconate (CAS 18472-51-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Chlorhexidine Gluconate?
Chlorhexidine Gluconate has 1,999 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain, Asthenia, Blood pressure increased, Dehydration, Drug hypersensitivity. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Chlorhexidine Gluconate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Chlorhexidine Digluconate with EU status "restricted".
What clinical phase is Chlorhexidine Gluconate in?
Chlorhexidine Gluconate is rendered with ChEMBL max phase 4 (approved).